Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

Stopped early

Conditions studied: Peyronie's Disease

In brief

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.

Key facts

Study ID

NCT05873595

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

29

Starts

2023-06-20

Expected to finish

2024-02-26

Last updated by the study team

2024-04-16

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Endo Pharmaceuticals Clinical Site 2 — San Diego, California, United States
• Endo Pharmaceuticals Clinical Site 3 — Miami, Florida, United States
• Endo Pharmaceuticals Clinical Site 6 — Greenwood, Indiana, United States
• Endo Pharmaceuticals Clinical Site 5 — Lansing, Michigan, United States
• Endo Pharmaceuticals Clinical Site 7 — Gahanna, Ohio, United States
• Endo Pharmaceuticals Clinical Site 4 — Houston, Texas, United States
• Endo Pharmaceuticals Clinical Site 1 — Orem, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.